mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.003 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.005 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.43 |
0.006 |